Postdischarge Anticoagulation Use Reduces VTE Risk After COVID-19 Hospitalization
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
Patients with history of VTE, peak D-dimer ≥3 μg/mL, and predischarge CRP ≥10 mg/dL were at high risk of experiencing new onset of VTE after hospital discharge.
The post-hoc analysis found tenapanor significantly improved weekly scores for abdominal pain, discomfort, and bloating, as measured by the Abdominal Score.
Following this analysis, the conclusions provide more information on the views of potential dermatology patients on the future of their own medical images by artificial…
Vadadustat tablets are now approved for the treatment of anemia due to CKD in adults who have been receiving dialysis for ≥ 3 months.
Join us April 01 on Twitter for a pre-meeting Tweet chat ahead of the American College of Cardiology’s 2024 annual meeting!
Mohamed Cherry, MD, and Neil Kramer, MD, shed light on a phase 1 trial using CAR-T cell therapy for SLE and its potential implications for…
Following this analysis, the conclusions provide more information on the views of potential dermatology patients on the future of their own medical images by artificial…
A hypothetical triennial blood-based screening test meeting Centers for Medicare and Medicaid Services coverage criteria was cost-effective versus no screening but not compared to FIT,…
In this analysis from the UK, the DDPS led to improved pathway management which also achieved lower service demand and smaller waiting lists for dermatologists.
This clinical quiz will test your knowledge on the use of non-statin therapies for LDL-C lowering based on the American College of Cardiology’s 2022 Expert…
The FDA identified high concentration of lidocaine across marketed, over-the-counter topical products from 6 different companies.